Sign in

You're signed outSign in or to get full access.

VH

Verano Holdings Corp. (VRNOF)·Q3 2025 Earnings Summary

Executive Summary

  • Q3 revenue was $202.8M, up slightly quarter-over-quarter (+0.3% q/q) but down year-over-year (-6.4% y/y), with gross margin compressing to 47% amid price pressure and promotions; Adjusted EBITDA was $53.1M (26% margin). Drivers included price compression/competition and higher short-term COGS from operational enhancements .
  • Results vs S&P Global consensus: revenue modestly beat (+$0.25M, +0.1%); EPS missed (actual -$0.0599 vs -$0.0465 consensus); EBITDA missed (actual $46.24M vs $59.96M consensus). Values retrieved from S&P Global*.
  • Net loss widened to -$43.8M due to a $5M impairment and $10M legal loss contingencies (partly offset by lower taxes vs prior year) .
  • Strategic/catalyst updates: shareholder approval to redomicile to Nevada (completion pending BC Registrar strike), a new $75M revolver ($50M drawn to retire higher-rate debt), retail footprint expansions (Zen Leaf Antwerp, MÜV Crystal River), and product innovation (HYPHEN modular vape, Edie Parker partnership) .

What Went Well and What Went Wrong

What Went Well

  • Adjusted EBITDA of $53.1M (26% margin) and SG&A reduced to $80.6M (40% of revenue), reflecting operating efficiencies and discipline; management emphasized groundwork for long-term growth and stronger wholesale/brand performance .
  • Balance sheet actions: secured a $75M revolver, drew $50M to retire higher-rate debt with no prepayment penalty, preserving $25M for strategic initiatives; working capital stood at $242M, with $82.6M cash on hand at quarter-end .
  • Network and product momentum: opened Zen Leaf Antwerp (sixth Ohio dispensary), MÜV Crystal River (82nd in Florida), launched HYPHEN modular vape system and an exclusive Edie Parker partnership to drive brand and category innovation .

What Went Wrong

  • Gross margin fell to 47% from 56% in Q2 and 50% in Q3’24 due to promotions and higher short-term COGS tied to operational enhancements; revenue declined y/y on price compression and competition .
  • Net loss widened to -$43.8M, impacted by a $5.4M impairment (fixed/held-for-sale assets) and $10M legal loss contingencies; other income/expense swung negative, pressuring bottom line .
  • Consensus misses: EPS and EBITDA came in below S&P Global expectations, reflecting margin pressure and non-operating items. Values retrieved from S&P Global*.

Financial Results

Income Statement and Profitability (Quarterly)

MetricQ3 2024Q1 2025Q2 2025Q3 2025
Revenue ($USD Millions)$216.683 $209.809 $202.272 $202.810
Gross Profit ($USD Millions)$109.097 $99.581 $112.984 $95.237
Gross Margin %50% 47% 56% 47%
Operating Income ($USD Millions)$16.770 $15.002 $26.211 $9.277
Net Income - (IS) ($USD Millions)-$42.567 -$11.515 -$19.150 -$43.832
EBITDA ($USD Millions)$52.547 $51.187 $61.697 $29.381
Adjusted EBITDA ($USD Millions)$64.458 $54.398 $66.153 $53.109
Adjusted EBITDA Margin %30% 26% 33% 26%

EPS Trend (company EPS from S&P Global)

MetricQ1 2025Q2 2025Q3 2025
Diluted EPS - Continuing Operations ($USD)-$0.0321*-$0.0531*-$0.1212*

Values retrieved from S&P Global*.

Cash Flow and Capex

MetricQ3 2024Q1 2025Q2 2025Q3 2025
Net Cash from Operations ($USD Millions)$30 $2 $11 $26
Capital Expenditures ($USD Millions)$57 $14 $10 $8

Balance Sheet KPIs (end of period)

KPIQ3 2025
Cash & Cash Equivalents ($USD Millions)$82.6
Working Capital ($USD Millions)$242
Total Debt, net ($USD Millions)$401
Class A Subordinate Voting Shares Outstanding361,815,879
Dispensaries / States / Production Facilities158 / 13 / 15
Cultivation Capacity (sq ft)>1.1 million
Revolving Credit Facility (Committed/Drawn/Available)$75M / $50M / $25M

Estimates vs Actuals (S&P Global)

MetricQ3 2025 ActualQ3 2025 ConsensusSurprise ($)Surprise (%)# of Estimates
Revenue ($USD Millions)$202.810 $202.557*+$0.253+0.1%7*
Primary EPS ($USD)-$0.0599*-$0.0465*-$0.0134N/A4*
EBITDA ($USD Millions)$46.237*$59.957*-$13.720-22.9%N/A

Values retrieved from S&P Global*. Note: Company-reported Adjusted EBITDA was $53.109M (26% margin), which is not directly comparable to S&P Global “EBITDA” consensus .

Segment Breakdown

SegmentQ3 2025
Not disclosed in the press releaseN/A

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
RevenueFY/Q4 2025Not providedNot providedMaintained (no formal guidance)
Gross MarginFY/Q4 2025Not providedNot providedMaintained (no formal guidance)
SG&A / OpExFY/Q4 2025Not providedNot providedMaintained (no formal guidance)
Tax RateFY/Q4 2025Not providedNot providedMaintained (no formal guidance)

Management commentary referenced ambition to “close the year on a high note” and highlighted ongoing efficiency and brand/wholesale initiatives, but the company did not provide quantitative guidance ranges in Q3 materials .

Earnings Call Themes & Trends

Note: A Q3 2025 earnings call/webcast was scheduled and link provided, but a transcript was not available in the document catalog for review .

TopicPrevious Mentions (Q1 & Q2)Current Period (Q3)Trend
Operational efficiency & marginsQ1: automation tech and streamlining; Q2: more efficient yields, margin improvement focus Emphasis on generating efficiencies, improving wholesale and brand performance Continued focus
Wholesale AR strategyQ2: impacts from wholesale accounts receivable strategy on revenue Focus on improving wholesale performance Stabilizing priority
Product innovationQ1: Savvy Strut 2g AIO, diamond-infused pre-rolls ; Q2: innovation continues Launch of HYPHEN modular vape; Edie Parker partnership; holiday season innovation Accelerating
Price compression/macroOngoing in Q1 and Q2, cited as key revenue headwind Continued pressure from price compression and competition Persistent headwind
Regulatory/legalCorporate transitions; leadership changes (Q2) Shareholder approval to redomicile to Nevada (completion pending); legal settlement (Vireo) De-risking corporate/legal
FinancingQ1: $12M real estate financing $75M revolver secured; $50M used to retire higher-rate debt Strengthened liquidity

Management Commentary

  • “This quarter reflects our hard work positioning Verano ahead of long-term growth opportunities by investing in infrastructure, generating efficiencies, improving wholesale and brand performance, and strengthening our capital structure and financial foundation for the future.” — George Archos, Founder, Chairman & CEO .
  • “With more exciting new product innovation planned for the busy retail holiday season... we look forward to closing the year on a high note and hitting the ground running in what we hope will be a transformative year for Verano and the industry in 2026.” — George Archos .

Q&A Highlights

  • The company scheduled a Q3 call/webcast and provided registration and webcast links, but an earnings call transcript was not available in the catalog; therefore, specific Q&A themes and clarifications cannot be provided from primary transcripts .

Estimates Context

  • Revenue slightly beat S&P Global consensus ($202.81M actual vs $202.56M estimate); EPS missed (actual -$0.0599 vs -$0.0465 estimate); EBITDA missed (actual $46.24M vs $59.96M estimate). Values retrieved from S&P Global*.
  • Consensus may need to reflect continued gross margin pressure from promotions and operational enhancements and the impact of non-operating items (impairments, legal contingencies) on profitability noted in Q3 .

Key Takeaways for Investors

  • Margins compressed sharply q/q (gross margin 47% vs 56% in Q2) on promotions and short-term COGS increases; watch for margin recovery as operational enhancements mature .
  • Revenue trajectory is stabilizing q/q (+0.3%) but remains lower y/y (-6.4%); price compression and competition remain core headwinds .
  • Liquidity improved: $75M revolver ($50M used to retire higher-rate debt) plus $82.6M cash and $242M working capital; enhances flexibility for strategic initiatives .
  • Adjusted EBITDA held at $53.1M despite top-line and margin pressures, evidencing cost control in SG&A ($80.6M, 40% of revenue) .
  • Near-term catalysts: redomicile completion to Nevada (pending BC Registrar strike resolution), continued retail expansion, and product launches (HYPHEN, Edie Parker) that could support brand mix and retail traffic .
  • Non-GAAP reconciliation shows sizable add-backs across COGS and SG&A plus “Acquisition Adjustments and Other Income & Expense”; investors should anchor valuation on consistent GAAP-to-non-GAAP bridges .
  • Without formal guidance, monitor holiday season sell-through, wholesale accounts receivable dynamics, and margin cadence into Q4 as key drivers of estimate revisions and stock narrative .

Footnote: Values retrieved from S&P Global* for estimates and EPS where noted.